OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Unlocking the Potential: Biomarkers of Response to Antibody-Drug Conjugates
Liliana Ascione, Lorenzo Guidi, Ajay Prakash, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 10
Liliana Ascione, Lorenzo Guidi, Ajay Prakash, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 10
Showing 10 citing articles:
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 9
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 9
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing
Tess A. O’Meara, Paolo Tarantino, Stefania Morganti, et al.
Current Oncology Reports (2025)
Closed Access
Tess A. O’Meara, Paolo Tarantino, Stefania Morganti, et al.
Current Oncology Reports (2025)
Closed Access
Five-gene expression signature associated with acquired FOLFIRI resistance and survival in metastatic colorectal cancer.
Elise Pretzsch, Christian Peschel, Matjaž Rokavec, et al.
Laboratory Investigation (2025), pp. 104107-104107
Open Access
Elise Pretzsch, Christian Peschel, Matjaž Rokavec, et al.
Laboratory Investigation (2025), pp. 104107-104107
Open Access
Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target
Giannis Mountzios, Stephanie P.L. Saw, Lizza E.L. Hendriks, et al.
Cancer Treatment Reviews (2025) Vol. 134, pp. 102902-102902
Closed Access
Giannis Mountzios, Stephanie P.L. Saw, Lizza E.L. Hendriks, et al.
Cancer Treatment Reviews (2025) Vol. 134, pp. 102902-102902
Closed Access
Polysaccharides as therapeutic vehicles in pancreatic cancer
Seema Kumari, Sujatha Peela, Ganji Purnachandra Nagaraju, et al.
Drug Discovery Today (2025), pp. 104320-104320
Closed Access
Seema Kumari, Sujatha Peela, Ganji Purnachandra Nagaraju, et al.
Drug Discovery Today (2025), pp. 104320-104320
Closed Access
Current Status and Future Prospects of TROP-2 ADCs in Lung Cancer Treatment
Mingyi Li, Jin Meng, Peng Hao, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5005-5021
Open Access | Times Cited: 2
Mingyi Li, Jin Meng, Peng Hao, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5005-5021
Open Access | Times Cited: 2
Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future Perspectives
Carol Zanchetta, Lorenzo De Marchi, Marianna Macerelli, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 221-221
Open Access | Times Cited: 2
Carol Zanchetta, Lorenzo De Marchi, Marianna Macerelli, et al.
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 221-221
Open Access | Times Cited: 2
Expanding the repertoire of Antibody Drug Conjugate (ADC) targets with improved tumor selectivity and range of potent payloads through in-silico analysis
Umesh Kathad, Neha Biyani, Raniero L. Peru y Colón De Portugal, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308604-e0308604
Open Access | Times Cited: 1
Umesh Kathad, Neha Biyani, Raniero L. Peru y Colón De Portugal, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0308604-e0308604
Open Access | Times Cited: 1
Addressing the unmet need in NSCLC progression with advances in second-line therapeutics
Kaige Wang, Alexis Leyba, Robert Hsu
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 6, pp. 1297-1320
Open Access
Kaige Wang, Alexis Leyba, Robert Hsu
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 6, pp. 1297-1320
Open Access
